147 related articles for article (PubMed ID: 33886682)
1. Methylomic analysis identifies C11orf87 as a novel epigenetic biomarker for GI cancers.
Tran MTMT; Yeh KT; Chuang YM; Hsu PY; Low JT; Kumari H; Lee YT; Chen YC; Huang WH; Jin H; Lin SH; Chan MWY
PLoS One; 2021; 16(4):e0250499. PubMed ID: 33886682
[TBL] [Abstract][Full Text] [Related]
2. Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer.
Wei KL; Chou JL; Chen YC; Jin H; Chuang YM; Wu CS; Chan MWY
PLoS One; 2019; 14(6):e0218338. PubMed ID: 31194837
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer.
Yeh CM; Chang LY; Lin SH; Chou JL; Hsieh HY; Zeng LH; Chuang SY; Wang HW; Dittner C; Lin CY; Lin JM; Huang YT; Ng EK; Cheng AS; Wu SF; Lin J; Yeh KT; Chan MW
Sci Rep; 2016 Aug; 6():31690. PubMed ID: 27528092
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer.
Wei KL; Chou JL; Chen YC; Low JT; Lin GL; Liu JL; Chang TS; Chen WM; Hsieh YY; Yan PS; Chuang YM; Lin JMJ; Wu SF; Chiang MK; Li C; Wu CS; Chan MWY
Front Oncol; 2021; 11():575667. PubMed ID: 33718136
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation and anti-tumorigenic effects of SH2-containing protein tyrosine phosphatase 1 (SHP1) in human gastric cancer cells.
Joo MK; Park JJ; Yoo HS; Lee BJ; Chun HJ; Lee SW; Bak YT
Tumour Biol; 2016 Apr; 37(4):4603-12. PubMed ID: 26508024
[TBL] [Abstract][Full Text] [Related]
6. Long Interspersed Element-1 Methylation Level as a Prognostic Biomarker in Gastrointestinal Cancers.
Baba Y; Yagi T; Sawayama H; Hiyoshi Y; Ishimoto T; Iwatsuki M; Miyamoto Y; Yoshida N; Baba H
Digestion; 2018; 97(1):26-30. PubMed ID: 29393154
[TBL] [Abstract][Full Text] [Related]
7. Methylation of the claudin‑3 promoter predicts the prognosis of advanced gastric adenocarcinoma.
Zhang Z; Yu W; Chen S; Chen Y; Chen L; Zhang S
Oncol Rep; 2018 Jul; 40(1):49-60. PubMed ID: 29749528
[TBL] [Abstract][Full Text] [Related]
8. Alteration in DNA methylation patterns: Epigenetic signatures in gastrointestinal cancers.
Heydari Z; Moeinvaziri F; Mirazimi SMA; Dashti F; Smirnova O; Shpichka A; Mirzaei H; Timashev P; Vosough M
Eur J Pharmacol; 2024 Jun; 973():176563. PubMed ID: 38593929
[TBL] [Abstract][Full Text] [Related]
9. Aberrant JAK/STAT Signaling Suppresses TFF1 and TFF2 through Epigenetic Silencing of GATA6 in Gastric Cancer.
Wu CS; Wei KL; Chou JL; Lu CK; Hsieh CC; Lin JM; Deng YF; Hsu WT; Wang HM; Leung CH; Ma DL; Li C; Chan MW
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598141
[TBL] [Abstract][Full Text] [Related]
10. Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.
Peyser ND; Freilino M; Wang L; Zeng Y; Li H; Johnson DE; Grandis JR
Oncogene; 2016 Mar; 35(9):1163-9. PubMed ID: 25982282
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
13. GFRA3 promoter methylation may be associated with decreased postoperative survival in gastric cancer.
Eftang LL; Klajic J; Kristensen VN; Tost J; Esbensen QY; Blom GP; Bukholm IR; Bukholm G
BMC Cancer; 2016 Mar; 16():225. PubMed ID: 26984265
[TBL] [Abstract][Full Text] [Related]
14. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
15. Loss of trefoil factor 1 is regulated by DNA methylation and is an independent predictive factor for poor survival in advanced gastric cancer.
Tanaka T; Nakamura J; Kitajima Y; Kai K; Miyake S; Hiraki M; Ide T; Koga Y; Noshiro H
Int J Oncol; 2013 Mar; 42(3):894-902. PubMed ID: 23291975
[TBL] [Abstract][Full Text] [Related]
16. DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer.
Kawamura YI; Toyota M; Kawashima R; Hagiwara T; Suzuki H; Imai K; Shinomura Y; Tokino T; Kannagi R; Dohi T
Gastroenterology; 2008 Jul; 135(1):142-151.e3. PubMed ID: 18485915
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic pathogenesis of human papillomavirus in upper aerodigestive tract cancers.
Talukdar FR; Ghosh SK; Laskar RS; Kannan R; Choudhury B; Bhowmik A
Mol Carcinog; 2015 Nov; 54(11):1387-96. PubMed ID: 25213493
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.
Vedeld HM; Goel A; Lind GE
Semin Cancer Biol; 2018 Aug; 51():36-49. PubMed ID: 29253542
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.
Baba Y; Murata A; Watanabe M; Baba H
Surg Today; 2014 Oct; 44(10):1807-16. PubMed ID: 24150097
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation attenuates SHP1 expression and function in patients with primary central nervous system lymphoma.
Liu J; Wang Y; Sun X; Ji N; Sun S; Wang Y; Liu F; Cui Q; Wang C; Liu Y
Oncol Rep; 2017 Feb; 37(2):887-894. PubMed ID: 27959415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
